Selank and Semax are both Russian-developed peptides with decades of research behind them, but they have distinct mechanisms and applications. Here's a detailed comparison.
Semax (ACTH 4-10 analog):
Semax is a synthetic analog of ACTH (adrenocorticotropic hormone) fragment 4-10. It was developed at the Institute of Molecular Genetics in Russia and has been used clinically there since the 1990s. Its primary mechanism involves BDNF (brain-derived neurotrophic factor) upregulation, which promotes neuronal survival, growth, and synaptic plasticity.
Reported research effects: improved focus and concentration, enhanced memory consolidation, neuroprotective properties, reduced brain fog, and improved verbal fluency. Some researchers also report mild mood elevation.
Administration: Intranasal is the most common route, typically 200-600mcg per day divided into 2-3 doses. Some researchers use subcutaneous injection. Intranasal absorption is generally considered adequate for this peptide due to its small size.
Selank (tuftsin analog):
Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, with a stabilizing Pro-Gly-Pro sequence added. Developed at the same Russian institute. Its primary mechanism involves modulation of GABA, serotonin, and dopamine systems, plus immune system regulation through IL-6 and T-cell modulation.
Reported research effects: anxiolytic (anti-anxiety) effects without sedation, improved stress resilience, mood stabilization, cognitive enhancement particularly under stress, and immune system support.
Administration: Also primarily intranasal, 200-400mcg per day divided into 2-3 doses. Can also be injected subcutaneously.
The key difference:
Semax is primarily a cognitive enhancer and neuroprotectant. It makes you sharper. Selank is primarily an anxiolytic with cognitive benefits. It makes you calmer and clearer, especially under stress. They're complementary, not competing — many researchers run both simultaneously.
Combination protocol (commonly reported):
Semax 300mcg intranasal in the morning for cognitive activation. Selank 300mcg intranasal midday or afternoon for stress management. Some researchers add a second Semax dose around noon if cognitive demands are high.
N-Acetyl variants:
Both peptides have N-Acetyl versions (NA-Semax, NA-Selank) which are reported to have enhanced bioavailability and longer duration of action. The N-Acetyl versions are generally more expensive but require less frequent dosing.
Important sourcing note:
Both peptides originate from Russian research, and most vendors source from Russian or Chinese labs. Quality variation exists. Look for vendors who provide HPLC purity testing specific to these peptides. The intranasal formulation should be a clear solution — cloudiness or particulates indicate contamination or degradation.
Close, but I’d word it carefully. Adamax is not simply the N-Acetyl version of Semax; it’s a separate Semax-family analog with additional structural modification. For Selank, Adalank is commonly used to refer to N-Acetyl Selank Amidate, but since vendor naming can vary, the most accurate way to confirm is by checking the listed sequence. For the N-acetyl/amidated Selank form, the sequence should be Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH₂.
Sources I found support that Adamax is listed separately from N-Acetyl Semax Amidate and described as a synthetic Semax derivative/adamantane-modified analog, while N-Acetyl Selank Amidate is described with the acetylated/amidated Selank sequence.
This detailed comparative sorting is very valuable for academic research reference. From the existing published research data, the two peptides indeed have different molecular action pathways and research positioning: Semax focuses more on neurotrophic regulation related to BDNF for neural protection and cognitive research, while Selank mainly acts on neurotransmitter regulation and immune modulation pathways. It is worth noting that most of the current conclusions are derived from preclinical and laboratory research observations, and inter-individual differences in experimental effects need to be fully considered in follow-up research design. Clarifying their complementary mechanisms rather than competitive relations can help researchers select more appropriate research objects according to different experimental purposes.
